[PREPRINT] RCT | Inhaled fluticasone not beneficial for outpatients with Covid-19.
25 Jul, 2022 | 13:01h | UTCNews Release: Study finds no benefit to taking fluticasone furoate for COVID-19 symptoms – Duke Clinical Research Institute
Commentary: Asthma Drug Fluticasone Fails as Potential COVID-19 Treatment – HealthDay